Currently participating in the Extended Phase III clinical trial of Pyrilutamid in China

    Technology 10/25/2023
    A user from China is participating in a clinical trial for Pyrilutamid, a potential hair loss treatment originally developed for prostate cancer. They've experienced no side effects except initial scalp itchiness, and will share results after the year-long trial.
    View this post in the Community →

    Similar Community Posts Join

    6 / 727 results

    Related Research

    6 / 7 results